Journey Medical (DERM) Accumulated Expenses (2020 - 2025)
Historic Accumulated Expenses for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to $21.2 million.
- Journey Medical's Accumulated Expenses rose 3239.01% to $21.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.2 million, marking a year-over-year increase of 3239.01%. This contributed to the annual value of $17.4 million for FY2024, which is 1437.35% down from last year.
- According to the latest figures from Q3 2025, Journey Medical's Accumulated Expenses is $21.2 million, which was up 3239.01% from $22.6 million recorded in Q2 2025.
- Over the past 5 years, Journey Medical's Accumulated Expenses peaked at $26.0 million during Q3 2021, and registered a low of $16.0 million during Q2 2024.
- For the 5-year period, Journey Medical's Accumulated Expenses averaged around $20.3 million, with its median value being $20.0 million (2024).
- In the last 5 years, Journey Medical's Accumulated Expenses plummeted by 3287.62% in 2023 and then skyrocketed by 4120.96% in 2025.
- Over the past 5 years, Journey Medical's Accumulated Expenses (Quarter) stood at $22.7 million in 2021, then decreased by 14.71% to $19.4 million in 2022, then rose by 4.96% to $20.3 million in 2023, then decreased by 14.37% to $17.4 million in 2024, then grew by 21.62% to $21.2 million in 2025.
- Its last three reported values are $21.2 million in Q3 2025, $22.6 million for Q2 2025, and $23.0 million during Q1 2025.